Trinity Biotech PLC

TRIB

Company Profile

  • Business description

    Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

  • Contact

    IDA Business Park
    Bray, County Wicklow
    DublinA98 H5C8
    IRL

    T: +353 12769800

    E: [email protected]

    https://www.trinitybiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    401

Stocks News & Analysis

stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks

ASX energy share remains cheap despite strong outlook

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,935.0014.40-0.16%
CAC 408,157.9115.990.20%
DAX 4024,136.7253.190.22%
Dow JONES (US)49,167.7962.92-0.13%
FTSE 10010,362.9741.880.41%
HKSE25,679.78245.87-0.95%
NASDAQ24,887.1050.500.20%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,764.40110.54-0.86%
S&P 5007,173.918.830.12%
S&P/ASX 2008,710.7010.50-0.12%
SSE Composite Index4,078.647.71-0.19%

Market Movers